Its nuanced, and getting it wrong can have catastrophic consequences for your results
Research suggests that individuals with type 2 diabetes may have reduced GLP-1 secretion or diminished incretin effect compared to those without diabetes, though this finding is not universal across all studies
Lancet Oncol 20(2):282296 Garon EB et al (2014) Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
Cmo se calcula la dosis equivalente humana desde modelos animales
Follow-up care, progress monitoring, treatment adjustments and realistic long-term planning also matter
In terms of intellectual disability, Butler et al